Basal insulin secretion capacity predicts the initial response and maximum levels of beta‐hydroxybutyrate during therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin, in relation to weight loss

AIMS: To investigate predictors of the initial response of beta‐hydroxybutyrate (BHB) and maximum BHB (max‐BHB) values during long‐term therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin (TOFO), and to explore the association of the initial elevation of BHB with subsequent clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Yuichi, Nunoi, Kiyohide, Kaku, Kohei, Yoshida, Akihiro, Suganami, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973158/
https://www.ncbi.nlm.nih.gov/pubmed/31608549
http://dx.doi.org/10.1111/dom.13890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973158/
https://www.ncbi.nlm.nih.gov/pubmed/31608549
http://dx.doi.org/10.1111/dom.13890

Ejemplares similares